Presentation is loading. Please wait.

Presentation is loading. Please wait.

PDE5A is expressed by podocytes.

Published byΜάξιμος Παπαδόπουλος Modified over 6 years ago

Similar presentations

Presentation on theme: "PDE5A is expressed by podocytes."— Presentation transcript:

1 PDE5A is expressed by podocytes.
PDE5A is expressed by podocytes. RNA and protein were isolated from cultured podocytes and renal mouse cortex; subsequently, (A) PCR and (B) Western blot were performed to determine PDE5A expression in these samples. Glomerular PDE5A expression was confirmed by immunofluorescence staining of PDE5A. (C) Importantly, costaining with synaptopodin showed PDE5A expression in the podocytes; merge is a higher magnification of single-channel images. AB, antibody; NTC, no template control. Ramon Sonneveld et al. JASN 2017;28: ©2017 by American Society of Nephrology

Download ppt "PDE5A is expressed by podocytes."

Similar presentations

Takehiko Wada, Jeffrey W. Pippin, Yoshio Terada, Stuart J. Shankland 

Takehiko Wada, Jeffrey W. Pippin, Yoshio Terada, Stuart J. Shankland 
Increased expression of heparanase in overt diabetic nephropathy

Increased expression of heparanase in overt diabetic nephropathy
Volume 66, Issue 1, Pages (July 2004)

Volume 66, Issue 1, Pages (July 2004)
Pioglitazone treatment prevents TRPC6 overexpression and podocyte injury in the adriamycin (ADRIA)–induced nephropathy rat model for FSGS. ADRIA-induced.

Pioglitazone treatment prevents TRPC6 overexpression and podocyte injury in the adriamycin (ADRIA)–induced nephropathy rat model for FSGS. ADRIA-induced.
Inhibition of ILK by QLT-0267 suppresses type I and type III collagen expression and ameliorates interstitial collagen deposition and renal fibrosis after.

Inhibition of ILK by QLT-0267 suppresses type I and type III collagen expression and ameliorates interstitial collagen deposition and renal fibrosis after.
Inhibition of ILK by QLT-0267 reduces β-catenin accumulation and inhibits Snail1 expression in obstructive nephropathy. Inhibition of ILK by QLT-0267 reduces.

Inhibition of ILK by QLT-0267 reduces β-catenin accumulation and inhibits Snail1 expression in obstructive nephropathy. Inhibition of ILK by QLT-0267 reduces.
Sildenafil does not prevent TRPC6 overexpression and podocyte injury in adriamycin (ADRIA)–challenged podocyte-specific PPAR-γ KO mice. Sildenafil does.

Sildenafil does not prevent TRPC6 overexpression and podocyte injury in adriamycin (ADRIA)–challenged podocyte-specific PPAR-γ KO mice. Sildenafil does.
TGF-β1 induces ILK activity in renal tubular epithelial cells.

TGF-β1 induces ILK activity in renal tubular epithelial cells.
Inhibition of ILK restores epithelial ZO-1 and E-cadherin and inhibits fibronectin and Snail1 expression after TGF-β1 treatment. Inhibition of ILK restores.

Inhibition of ILK restores epithelial ZO-1 and E-cadherin and inhibits fibronectin and Snail1 expression after TGF-β1 treatment. Inhibition of ILK restores.
Downregulation of TRPC6 expression by sildenafil leads to reduced TRPC6–mediated Ca2+ influx into the podocyte. Downregulation of TRPC6 expression by sildenafil.

Downregulation of TRPC6 expression by sildenafil leads to reduced TRPC6–mediated Ca2+ influx into the podocyte. Downregulation of TRPC6 expression by sildenafil.
Volume 76, Issue 1, Pages (July 2009)

Volume 76, Issue 1, Pages (July 2009)
Differential expression of select miRNAs was validated in a second cohort of patients. Differential expression of select miRNAs was validated in a second.

Differential expression of select miRNAs was validated in a second cohort of patients. Differential expression of select miRNAs was validated in a second.
Podocyte-specific PPAR-γ–deficient mice show increased glomerular TRPC6 expression. Podocyte-specific PPAR-γ–deficient mice show increased glomerular TRPC6.

Podocyte-specific PPAR-γ–deficient mice show increased glomerular TRPC6 expression. Podocyte-specific PPAR-γ–deficient mice show increased glomerular TRPC6.
Inhibition of ILK activity does not affect normal kidney structure and nephrin/ILK interaction in vivo. Inhibition of ILK activity does not affect normal.

Inhibition of ILK activity does not affect normal kidney structure and nephrin/ILK interaction in vivo. Inhibition of ILK activity does not affect normal.
Inhibition of ILK by QLT-0267 abrogates PAI-1 and MMP-2 induction by TGF-β1 in tubular epithelial cells. Inhibition of ILK by QLT-0267 abrogates PAI-1.

Inhibition of ILK by QLT-0267 abrogates PAI-1 and MMP-2 induction by TGF-β1 in tubular epithelial cells. Inhibition of ILK by QLT-0267 abrogates PAI-1.
Figure 6. Representative micrographs showing macrophages and nitrotyrosine in atherosclerotic plaques in aortic root cross-sections from apo-E −/− mice.

Figure 6. Representative micrographs showing macrophages and nitrotyrosine in atherosclerotic plaques in aortic root cross-sections from apo-E −/− mice.
Figure 10. Recovery of the acetyl-CoA and ATP levels by glucose administration. Figure 10. Recovery of the acetyl-CoA and ATP levels by glucose administration.

Figure 10. Recovery of the acetyl-CoA and ATP levels by glucose administration. Figure 10. Recovery of the acetyl-CoA and ATP levels by glucose administration.
Volume 58, Issue 5, Pages (November 2000)

Volume 58, Issue 5, Pages (November 2000)
Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 12, Pages (June 2006)
Expression of somatostatin in the adult and developing mouse kidney

Expression of somatostatin in the adult and developing mouse kidney

Similar presentations

Ads by Google